Trial Profile
Phase III, randomized, multicenter, double-blind clinical trial to evaluate two echo-guided administration regimens of ibuprofen in the treatment of patent ductus arteriosus: impact on intestinal prognosis
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Jul 2022
Price :
$35
*
At a glance
- Drugs Ibuprofen lysinate (Primary)
- Indications Patent ductus arteriosus
- Focus Therapeutic Use
- Acronyms IBU24h-EchoG
- 18 Nov 2016 New trial record